[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Monopolies in publishing
- To: "'liblicense-l@lists.yale.edu'" <liblicense-l@lists.yale.edu>
- Subject: RE: Monopolies in publishing
- From: David Ball <dball@bournemouth.ac.uk>
- Date: Thu, 10 Jul 2003 17:17:25 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
Jan's first point is absolutely right: articles can only be obtained from one source. The author's monopoly is protected by copyright and normally transferred to the publisher. I disagree, in a hair-splitting way, with his second point. An open-access journal is still a monopoly if there is no alternative source. It may not be an effective monopoly if it doesn't charge (except of course for the entry-level of charge of a PC, a network etc.), but it's a monopoly all the same. An interesting dimension is of course the commercial publishers' effective near-monopoly on validation (through the editorial process). It's this validation that authors and their institutions want, and which we have to pay for. Dissemination is secondary. An interesting treatment is Jean-Claude Gu�don's well known 'In Oldenburg's long shadow: librarians, research scientists, publishers, and the control of scientific publishing', ARL proceedings, 138, May 2001, p.3; available at http://www.arl.org/arl/proceedings/138/guedon.html <http://www.arl.org/arl/proceedings/138/guedon.html> . Until this near-monopoly is broken open access journals will not compete with commercial publishing. With best wishes ********************************************* David Ball Associate Head of Academic Services (University Librarian) Bournemouth University Fern Barrow Poole, Dorset BH12 5BB UK Tel.: +44 (0)1202-595044 Fax.: +44 (0)1202-595475 Mob: 07971 027751 ********************************************* -----Original Message----- From: Jan Velterop [SMTP:jan@biomedcentral.com] Sent: 10 July 2003 17:03 To: 'liblicense-l@lists.yale.edu' Subject: RE: Monopolies in publishing It seems so obvious to me that subscription-based scientific journals are monopoloid. Research articles are only published once. They are by definition unique. Access to unique research articles is often crucial to further research. They can only be obtained from one ultimate source (albeit sometimes via agents). There is no opportunity to go to another, possibly cheaper, source to find something equivalent, because equivalents don't exist. So there is no choice if you need the article. No choice in need means monopoly, no? Authors of articles *do* have a choice of where to publish (at least where to submit their papers). They can choose to submit to those journals that serve their purpose best (e.g. to those that guarantee optimal dissemination via open access). Open access journals are freely accessible by the readers. This makes open access journals non-monopoloid. Jan Velterop BioMed Central
- Prev by Date: Re: Monopolies in publishing
- Next by Date: Cambridge Journals Online planned downtime
- Previous by thread: Re: Monopolies in publishing
- Next by thread: RE: Monopolies in publishing
- Index(es):